SBIR/STTR Research Award
A SIMPLE MULTIPLEXED PLATFORM FOR SELF-ADMINISTERED HIV AND HEPATITIS B TESTING
Award amount
$299,982Program and phase
SBIR · Phase IAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BAEBIES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NZSZBQ9B84T1
- Solicitation number
- PHS-2024-1
- Topic code
- 127
Research abstract
Multiplexed Patient Administered Diagnostics for Hepatitis B, Hepatitis C, and HIV: HIV and viral hepatitis infections share common modes of transmission and social and structural barriers to accessing care and services among key populations. Coinfection with HIV significantly impacts the pathogenesis of HBV and HCV and is associated with reduced spontaneous clearance of HCV and HBsAg, higher rates of chronicity and occult HBV, higher HCV viral loads, rapid disease progression, and increased risk of morbidity and mortality due to cirrhosis and HCC. Integrated strategies for screening and diagnosis of HIV and viral hepatitis infections are therefore critical to an effective global health response. This contract aims to develop a novel, low-cost multiplexed analyzer capable of fully automating both molecular and immunoassay test formats using fingerstick blood samples for use by patients and untrained healthcare staff for detection of HIV-1 and HBV.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A MULTIFUNCTIONAL POINT-OF-CARE PLATFORM TO DIFFERENTIATE HIV INFECTION FROM VACCINE INDUCED SEROPOSITIVITY
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Development of a Wide Multiplexing, Multifunctional Platform for Flexible Diagnostics
- DEVELOPMENT OF A RAPID, QUANTITATIVE HIV-1 ASSAY FOR VIRAL LOAD SELF-MONITORING
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- AN EASY-TO-USE, LOW-COST TRIPLEX RDT FOR THE SIMULTANEOUS DIAGNOSIS OF HBV, HCV, AND HIV INFECTION, COMPATIBLE WITH FIELD USE IN LMICS AND AT-HOME USE IN THE US
- DEVELOPMENT OF AN ULTRASENSITIVE, RAPID AND EASY-TO USE AT-HOME MOLECULAR TEST FOR HCV, HBV AND HIV
Research funding history
45 SBIR/STTR records share this UEI (2014–2025). Reported award amounts total $42,450,057. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense